{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:16:47Z","timestamp":1783397807274,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["U955"],"award-info":[{"award-number":["U955"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009411","name":"Universit\u00e9 Paris-Est Cr\u00e9teil Val-de-Marne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101195","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:22:35Z","timestamp":1779726155000},"page":"101195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Primary adrenal insufficiency in patients with bilateral adrenal metastases treated with curative ablative radiation therapy: A comprehensive review of literature and expert agreements for radiation practice"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-6693","authenticated-orcid":false,"given":"Alexander","family":"Bennassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Debbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5209-3558","authenticated-orcid":false,"given":"Nicolas","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8315-570X","authenticated-orcid":false,"given":"Lahc\u00e8ne","family":"Bela\u00efdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Durigova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Salati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6439-2600","authenticated-orcid":false,"given":"Sami","family":"Frikha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5026-4245","authenticated-orcid":false,"given":"Fatima Zahra","family":"Bellefkih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Ksouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisrine El","family":"Hayel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6490-9278","authenticated-orcid":false,"given":"Pelagia","family":"Tsoutsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Geara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3885-0513","authenticated-orcid":false,"given":"Dusanka","family":"Tesanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6480-4583","authenticated-orcid":false,"given":"Sha\u00efma El","family":"Chammah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Ozsahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Droumaguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazid","family":"Belkacemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2026.101195_b0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","article-title":"Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital","volume":"56","author":"Lam","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101195_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cllc.2019.06.003","article-title":"Clinical characteristics, molecular phenotyping, and management of isolated adrenal metastases from lung cancer","volume":"20","author":"Mazzella","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ctro.2026.101195_b0015","article-title":"Adrenal insufficiency after stereotactic body radiation therapy for bilateral adrenal metastases. Pract","author":"Wardak","year":"2015","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101195_b0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cen.14911","article-title":"Radiation of bilateral adrenal metastases is associated with a high risk of primary adrenal insufficiency","volume":"99","author":"Herndon","year":"2023","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101195_b0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","article-title":"Stereotactic body radiotherapy for treatment of adrenal metastases","volume":"75","author":"Chawla","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101195_b0030","doi-asserted-by":"crossref","unstructured":"Lugat A, Drui D, Baron S, Thebaud E, Supiot S, Jouglar E, Dor\u00e9 M. Effets secondaires endocriniens de la radioth\u00e9rapie: diagnostic, pr\u00e9vention et traitements [Endocrine side effects of radiation therapy: Diagnosis, prevention, and treatment]. Cancer Radiother. 2022 Nov;26(8):1078-1089. French. doi: 10.1016\/j.canrad.2021.12.008.","DOI":"10.1016\/j.canrad.2021.12.008"},{"key":"10.1016\/j.ctro.2026.101195_b0035","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371\/journal.pmed.1000097. Epub 2009 Jul 21.","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"3","key":"10.1016\/j.ctro.2026.101195_b0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.radonc.2008.03.013","article-title":"Real-time tumor-tracking radiotherapy for adrenal tumors","volume":"87","author":"Katoh","year":"2008","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101195_b0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1607-551X(09)70136-6","article-title":"Management of bilateral adrenal metastases from hepatocellular carcinoma: a case report","volume":"21","author":"Hsieh","year":"2005","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"10.1016\/j.ctro.2026.101195_b0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/fon.10.165","article-title":"Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy","volume":"7","author":"Torok","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.ctro.2026.101195_b0075","doi-asserted-by":"crossref","unstructured":"Eldaya RW, Paulino AC, Blanco AI, Chiang S, South M, Lehane D, Teh BS. Preservation of adrenal function after successful stereotactic body radiation therapy of metastatic renal cell carcinoma involving the remaining contralateral adrenal gland. Pract Radiat Oncol. 2012 Oct-Dec;2(4):270-273. doi: 10.1016\/j.prro.2011.11.002. Epub 2011 Dec 11.","DOI":"10.1016\/j.prro.2011.11.002"},{"issue":"11","key":"10.1016\/j.ctro.2026.101195_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080654","article-title":"Treating adrenal tumors in 26 patients with CyberKnife: a mono-institutional experience","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ctro.2026.101195_b0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/tj.5000222","article-title":"Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer","volume":"101","author":"Gamsiz","year":"2015","journal-title":"Tumori"},{"issue":"3","key":"10.1016\/j.ctro.2026.101195_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152642","article-title":"Radiotherapy for adrenal metastasis from hepatocellular carcinoma: a multi-institutional retrospective study (KROG 13-05)","volume":"11","author":"Jung","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ctro.2026.101195_b0100","doi-asserted-by":"crossref","unstructured":"Chance WW, Nguyen QN, Mehran R, Welsh JW, Gomez DR, Balter P, Komaki R, Liao Z, Chang JY. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. Pract Radiat Oncol. 2017 May-Jun;7(3):e195-e203. doi: 10.1016\/j.prro.2016.09.005. Epub 2016 Sep 13.","DOI":"10.1016\/j.prro.2016.09.005"},{"issue":"3","key":"10.1016\/j.ctro.2026.101195_b0195","first-page":"e1120","article-title":"Robotic radiosurgery for adrenal gland metastases","volume":"9","author":"Haidenberger","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.ctro.2026.101195_b0210","doi-asserted-by":"crossref","unstructured":"Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, Pulipparacharuvil S, Choy H, Timmerman RD. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol. 2018 Jan 11;4(1):e173501. doi: 10.1001\/jamaoncol.2017.3501. Epub 2018 Jan 11.","DOI":"10.1001\/jamaoncol.2017.3501"},{"issue":"4","key":"10.1016\/j.ctro.2026.101195_b0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.adro.2018.05.006","article-title":"Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity","volume":"3","author":"Toesca","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101195_b0220","doi-asserted-by":"crossref","unstructured":"Burjakow K, Fietkau R, Putz F, Achterberg N, Lettmaier S, Knippen S. Fractionated stereotactic radiation therapy for adrenal metastases: contributing to local tumor control with low toxicity. Strahlenther Onkol. 2019 Mar;195(3):236-245. English. doi: 10.1007\/s00066-018-1390-3. Epub 2018 Oct 29.","DOI":"10.1007\/s00066-018-1390-3"},{"issue":"2","key":"10.1016\/j.ctro.2026.101195_b0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/COC.0000000000000634","article-title":"Novel dose escalation approaches for stereotactic body radiotherapy to adrenal oligometastases: a single-institution experience","volume":"43","author":"Figura","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2026.101195_b0200","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fonc.2019.00732","article-title":"Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases","volume":"7","author":"Scouarnec","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101195_b0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10585-020-10052-0","article-title":"Adrenal SBRT: a multi-institutional review of treatment outcomes and toxicity","volume":"37","author":"Helis","year":"2020","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ctro.2026.101195_b0225","doi-asserted-by":"crossref","unstructured":"Chen H, Schneiders FL, Bruynzeel AME, Lagerwaard FJ, van S\u00f6rnsen de Koste JR, Cobussen P, Bohoudi O, Slotman BJ, Louie AV, Senan S. Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy. Radiother Oncol. 2021 Oct;163:14-20. doi: 10.1016\/j.radonc.2021.07.026. Epub 2021 Jul 31.","DOI":"10.1016\/j.radonc.2021.07.026"},{"issue":"3","key":"10.1016\/j.ctro.2026.101195_b0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ijc.34017","article-title":"Stereotactic body radiotherapy of adrenal metastases-a dose-finding study","volume":"151","author":"Buergy","year":"2022","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2026.101195_b0120","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/CMR.0000000000000813","article-title":"Long-term control of melanoma adrenal metastasis treated with radiotherapy","volume":"32","author":"McCann","year":"2022","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1016\/j.ctro.2026.101195_b0055","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00432-022-03943-0","article-title":"Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis","volume":"149","author":"Ehret","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2026.101195_b0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1159\/000527052","article-title":"Stereotactic radiotherapy for adrenal metastases: a multi-institutional review of patient characteristics and outcomes - turkish society for radiation oncology SBRT group study (Trod SBRT 10-004)","volume":"45","author":"Elmali","year":"2022","journal-title":"Oncol Res Treat"},{"issue":"43","key":"10.1016\/j.ctro.2026.101195_b0080","article-title":"Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk","volume":"24","author":"Schneiders","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"issue":"47","key":"10.1016\/j.ctro.2026.101195_b0105","article-title":"Total dose, fraction dose and respiratory motion management impact adrenal SBRT outcome","volume":"4","author":"Haisraely","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"issue":"18","key":"10.1016\/j.ctro.2026.101195_b0065","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.3390\/cancers16183140","article-title":"Adrenal insufficiency following stereotactic ablative radiotherapy (SAbR) of adrenal gland metastases","volume":"16","author":"Hamidi","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"45","key":"10.1016\/j.ctro.2026.101195_b0095","article-title":"Stereotactic body radiation therapy for adrenal gland metastases: a multi-institutional outcome analysis","volume":"7","author":"Yuste","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"issue":"15","key":"10.1016\/j.ctro.2026.101195_b0070","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3390\/cancers16152655","article-title":"Retrospective analysis of efficacy and toxicity of stereotactic body radiotherapy and surgical resection of adrenal metastases from solid tumors","volume":"16","author":"L\u00fctscher","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"46","key":"10.1016\/j.ctro.2026.101195_b0115","article-title":"Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases","volume":"29","author":"Ugurluer","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2026.101195_b0125","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3390\/cancers16122273","article-title":"Clinical outcomes of online adaptive magnetic resonance-guided stereotactic body radiotherapy of adrenal metastases from a single institution","volume":"16","author":"Hoegen-Sa\u00dfmannshausen","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ctro.2026.101195_b0130","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis","volume":"26","author":"Tanvetyanon","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101195_b0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jso.2930430306","article-title":"Do adrenal metastases from lung cancer develop by lymphogenous or hematogenous route?","volume":"43","author":"K\u00e1rolyi","year":"1990","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101195_b0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","article-title":"Stereotactic body radiotherapy in the treatment of adrenal metastases","volume":"36","author":"Ahmed","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101195_b0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7785\/tcrt.2012.500320","article-title":"Stereotactic body radiation therapy for curative treatment of adrenal metastases","volume":"12","author":"Rudra","year":"2013","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ctro.2026.101195_b0155","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a european society for radiotherapy and oncology and european organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101195_b0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101195_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110235","article-title":"Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study","volume":"195","author":"Christ","year":"2024","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101195_b0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2020.01.017","article-title":"Stereotactic body radiation therapy of adrenal metastases: a pooled meta-analysis and systematic review of 39 studies with 1006 patients","volume":"107","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101195_b0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A Story of Hypofractionation and the Table on the Wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10185","key":"10.1016\/j.ctro.2026.101195_b0175","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ctro.2026.101195_b0235","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ando.2017.10.007","article-title":"Group 4: Replacement therapy for adrenal insufficiency","volume":"78","author":"Castinetti","year":"2017","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ctro.2026.101195_b0180","doi-asserted-by":"crossref","unstructured":"Palacios MA, Bohoudi O, Bruynzeel AME, van S\u00f6rsen de Koste JR, Cobussen P, Slotman BJ, Lagerwaard FJ, Senan S. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases. Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):426-433. doi: 10.1016\/j.ijrobp.2018.06.002. Epub 2018 Jun 11.","DOI":"10.1016\/j.ijrobp.2018.06.002"},{"issue":"6","key":"10.1016\/j.ctro.2026.101195_b0230","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ando.2017.10.005","article-title":"Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis","volume":"78","author":"Chanson","year":"2017","journal-title":"Ann Endocrinol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:42:12Z","timestamp":1783395732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082600090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"alternative-id":["S240563082600090X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101195","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary adrenal insufficiency in patients with bilateral adrenal metastases treated with curative ablative radiation therapy: A comprehensive review of literature and expert agreements for radiation practice","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101195"}}